|
WO2021081407A1
|
|
Thienoazepine immunoconjugates, and uses thereof
|
|
WO2021081402A1
|
|
Macromolecule-supported thienoazepine compounds, and uses thereof
|
|
WO2021067242A1
|
|
Amide-linked, aminobenzazepine immunoconjugates, and uses thereof
|
|
WO2021046347A1
|
|
Immunoconjugate synthesis method
|
|
WO2021046112A1
|
|
Aminoquinoline compounds, immunoconjugates, and uses thereof
|
|
WO2020252254A1
|
|
Macromolecule-supported aminobenzazepine compounds
|
|
WO2020252294A1
|
|
Aminobenzazepine compounds, immunoconjugates, and uses thereof
|
|
WO2020190731A1
|
|
Immunoconjugates targeting her2
|
|
WO2020190725A1
|
|
Immunoconjugates targeting her2
|
|
WO2020190734A1
|
|
Immunoconjugates targeting pd-l1
|
|
WO2020190762A1
|
|
Macromolecule-supported tlr agonists
|
|
WO2020190760A1
|
|
Immunoconjugates targeting cea
|
|
AU2019330977A1
|
|
Immunoconjugates targeting EGFR
|
|
CN112153988A
|
|
Immunoconjugates
|
|
EP3609540A1
|
|
Immunoconjugate synthesis method
|
|
EP3554550A1
|
|
Antibody adjuvant conjugates
|
